Consolidated Statements Of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Sales		$ 390,381
Operating expenses
General and administrative	3,702,156	4,528,437
Research and development		361,200
Total expenses	3,702,156	4,889,637
Loss from operations	(3,702,156)	(4,499,256)
Other income (expense)
Amortization of debt discount and interest expense	158,202	108,752
Loss on settlement of debt	(1,398,085)	(3,488,400)
Initial derivative expense	274,717
Change in fair value of derivative liabilities	(143,276)
Total other income (expense)	(1,974,280)	(3,597,152)
Net loss	$ (5,676,436)	$ (8,096,408)
Net loss per common share - basic and diluted	$ (15.50)	$ (176.14)
Weighted average number of common shares outstanding - basic and diluted	366,157	45,965